Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
S
SLD
vs
S
S&P/ASX 300
Over the past 12 months, SLD has underperformed S&P/ASX 300, delivering a return of -70% compared to S&P/ASX 300's 0% drop.
Stocks Performance
SLD vs S&P/ASX 300
Performance Gap
SLD vs S&P/ASX 300
Performance By Year
SLD vs S&P/ASX 300
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Saluda Medical Inc
Glance View
Saluda Medical, Inc. is a commercial-stage medical device company. The company is headquartered in Bloomington, Minnesota. The company went IPO on 2025-12-05. The Company’s closed-loop, dose-control platform is designed to sense and measure neural responses to stimulation and automatically adjust therapy based on real-time neurophysiological feedback. The company is focused on leveraging its platform to disrupt and grow the spinal cord stimulation (SCS) market for chronic pain. The Company’s product, Evoke System, is designed to treat chronic neuropathic pain by providing SCS therapy that senses and measures neural activation to optimize therapy and reduce patient and clinician burden. The Evoke System aids in the management of chronic intractable pain of the trunk and/or limbs, including unilateral or bilateral pain associated with failed back surgery syndrome, intractable lower back pain and leg pain.